haloperidol has been researched along with valproic acid in 117 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 15 (12.82) | 18.7374 |
1990's | 13 (11.11) | 18.2507 |
2000's | 49 (41.88) | 29.6817 |
2010's | 32 (27.35) | 24.3611 |
2020's | 8 (6.84) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Abraham, MH; Acree, WE; Ibrahim, A | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Atzpodien, EA; Csato, M; Doessegger, L; Fischer, H; Lenz, B; Schmitt, G; Singer, T | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Jones, LH; Nadanaciva, S; Rana, P; Will, Y | 1 |
Amata, E; Anfuso, CD; Arena, E; Caporarello, N; Drago, F; Fiorito, J; Giurdanella, G; Lupo, G; Marrazzo, A; Olivieri, M; Prezzavento, O; Rescifina, A; Salerno, L; Vinciguerra, S | 1 |
Filipek, B; Gunia-Krzyżak, A; Marona, H; Nitek, W; Pańczyk, K; Pękala, E; Rapacz, A; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D; Żesławska, E | 1 |
Agard, DA; Ashworth, A; Barrio-Hernandez, I; Batra, J; Beltrao, P; Bennett, MJ; Bohn, M; Bouhaddou, M; Braberg, H; Broadhurst, DJ; Cai, Y; Cakir, M; Calviello, L; Cavero, DA; Chang, JCJ; Chorba, JS; Craik, CS; d'Enfert, C; Dai, SA; Eckhardt, M; Emerman, M; Fabius, JM; Fletcher, SJ; Floor, SN; Foussard, H; Frankel, AD; Fraser, JS; Fujimori, DG; Ganesan, SJ; García-Sastre, A; Gordon, DE; Gross, JD; Guo, JZ; Haas, K; Haas, P; Hernandez-Armenta, C; Hiatt, J; Huang, XP; Hubert, M; Hüttenhain, R; Ideker, T; Jacobson, M; Jang, GM; Jura, N; Kaake, RM; Kim, M; Kirby, IT; Klippsten, S; Koh, C; Kortemme, T; Krogan, NJ; Kuzuoglu-Ozturk, D; Li, Q; Liboy-Lugo, J; Lin, Y; Liu, X; Liu, Y; Lou, K; Lyu, J; Mac Kain, A; Malik, HS; Mathy, CJP; McGregor, MJ; Melnyk, JE; Memon, D; Meyer, B; Miorin, L; Modak, M; Moreno, E; Mukherjee, S; Naing, ZZC; Noack, J; O'Meara, MJ; O'Neal, MC; Obernier, K; Ott, M; Peng, S; Perica, T; Pilla, KB; Polacco, BJ; Rakesh, R; Rathore, U; Rezelj, VV; Richards, AL; Roesch, F; Rosenberg, OS; Rosenthal, SB; Roth, BL; Roth, TL; Ruggero, D; Safari, M; Sali, A; Saltzberg, DJ; Savar, NS; Schwartz, O; Sharp, PP; Shen, W; Shengjuler, D; Shi, Y; Shoichet, BK; Shokat, KM; Soucheray, M; Stroud, RM; Subramanian, A; Swaney, DL; Taunton, J; Tran, QD; Trenker, R; Tummino, TA; Tutuncuoglu, B; Ugur, FS; Vallet, T; Venkataramanan, S; Verba, KA; Verdin, E; Vignuzzi, M; von Zastrow, M; Wang, HY; Wankowicz, SA; Wenzell, NA; White, KM; Xu, J; Young, JM; Zhang, Z; Zhou, Y | 1 |
Amata, E; Anfuso, CD; Barbaraci, C; Cacciatore, I; Dichiara, M; Giurdanella, G; Leotta, CG; Longo, A; Lupo, G; Marrazzo, A; Pasquinucci, L; Pitari, GM; Prezzavento, O; Turnaturi, R; Zuccarello, E | 1 |
Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Algeri, S; Branciforti, A; Calderini, G; Caraceni, T; Consolazione, A; Dall'olio, A; Girotti, F; Morselli, PL; Riva, E; Spreafico, R | 1 |
Avanzini, G; Caraceni, T; Giovannini, P; Girotti, F | 1 |
Godwin-Austen, RB | 1 |
Barrelet, L; Baumann, P; Touabi, M; Uehlinger, C | 1 |
Turner, WJ | 1 |
Cennamo, M; Piccione, E; Ticconi, C | 1 |
Naranjo, CA; Sellers, EM | 1 |
Drake, ME; John, K; Kellum, JB; Pakalnis, A | 1 |
Appleton, RE; Jan, JE | 1 |
Rogers, J; Troost, BT; Williams, DP | 1 |
Newman, G; Shukla, S; Turner, WJ | 1 |
Chiba, K; Iizuka, R; Ishizaki, T; Kobayashi, K; Saito, M | 1 |
Monninger, P; Przuntek, H | 1 |
Bourguignon, A; Cadet, B; Chaneac, D; de Medeiros, P; Monfort, JC | 1 |
Lal, S; Nair, NP; Schwartz, G; Thavundayil, JX | 1 |
Georgiev, V; Markovska, V | 1 |
Kirch, DG; Li, R; Wing, LL; Wyatt, RJ | 1 |
Finnerty, M; Levin, Z; Miller, LJ | 1 |
Bennett, JA; Keck, PE; McElroy, SL; Stanton, SP; Strakowski, SM; Tugrul, KC | 1 |
Barnett, JY; Brasić, JR | 1 |
Moore, DP | 1 |
Dose, M; Emrich, HM; Hellweg, R; Theison, M; Yassouridis, A | 1 |
Berger, M; Brandt, C; Normann, C; Walden, J | 1 |
Forleo, LH; Hilario, MO; Len, CA; Ronchezel, MV; Sole, D; Terreri, MT; Vilanova, LC | 1 |
Jaggers, ED; Kline, MD | 1 |
Berger, M; Hesslinger, B; Klose, P; Langosch, JM; Normann, C; Walden, J | 1 |
Giedke, H; Henn, FA; Müller-Oerlinghausen, B; Retzow, A; Walden, J | 1 |
Ahmed, W; Ghani, SO; Marco, LA | 1 |
Brown, A; Dott, SG; Harris, A; Meyer, WJ; O'Boyle, M; Rose, RM; Wassef, AA | 1 |
Hafiz, NG; Hampton, D; Molloy, M; Wassef, AA | 1 |
Gundlapalli, SP; Iqbal, MM; Passman, TE; Ryals, T; Ryan, WG | 1 |
Hardy-Baylé, MC | 1 |
Jagadheesan, K; Nizamie, SH; Ranjan, S | 1 |
Bhattacharya, D; Bhattacharya, SK; Ghosal, S; Sairam, K | 1 |
Araujo, AP; Maia Filho, HS; Padua, PA | 1 |
Bowden, CL; Ghaemi, SN; Grossman, F; Okamoto, A; Sachs, GS | 1 |
Cardozo, J; Molina, O; Montiel, C; Mora, E; Peña, J | 1 |
Assumpção, FB; Ribeiro, KM; Valente, KD | 1 |
Bhattachary, SK; Bhattacharya, D; Muruganandam, AV | 1 |
Agam, G; Belmaker, RH; Kozlovsky, N; Nadri, C | 1 |
Morita, N; Suetsugu, S | 1 |
Coffey, B | 1 |
Lopez, LM; Molloy, MS; Wassef, AA; Williams, NG | 1 |
Girimaji, SC; Jairam, R; Seshadri, SP; Srinath, S | 1 |
Bryois, Ch; Sahli, Ch | 1 |
Jainer, AK; Sundararajan, V | 1 |
Andrade, C | 1 |
Gupta, SB; Laghate, VD | 1 |
Winter, AS; Witschy, JK | 1 |
Canonico, PL; Colella, L; Dellarole, A; Ferri, S; Ghi, P; Orsetti, M | 1 |
Suryavanshi, P; Tadke, RR | 1 |
Donnelly, CA; Lamberton, PH; Torrey, EF; Webster, JP | 1 |
Canonico, PL; Colella, L; Dellarole, A; Ghi, P; Orsetti, M | 1 |
Cipriani, A; Geddes, JR; Rendell, JM | 1 |
Brecher, M; Nasrallah, HA; Paulsson, B | 1 |
Roberts-Thomson, KC; Teo, KS; Young, GD | 1 |
Brahm, NC; Carnahan, RM; Gutierres, SL | 1 |
Joo, YH; Kim, B; Kim, SJ; Son, JI | 1 |
Brodaty, H; Cumming, R; Forrester, L; Grayson, D; Hollis, J; Touyz, S | 2 |
Lorenz, RA; Weinstein, B | 1 |
Berk, M; Dodd, S; Lubman, DI; Ng, F; Tohen, M; Vieta, E; Wang, WV | 1 |
Donnelly, CA; Lamberton, PH; Webster, JP | 1 |
Costa, E; Dong, E; Grayson, DR; Guidotti, A; Nelson, M | 1 |
Kalra, B; Mendhekar, DN; Sekhar, S; Tekur, U | 1 |
Munhoz, RP; Teive, HA; Werneck, LC | 1 |
Avissar, S; Golan, M; Schreiber, G | 1 |
Di Cosimo, D; Girardi, N; Kotzalidis, GD; Lazanio, S; Manfredi, G; Savoja, V; Talamo, A; Tatarelli, R; Vento, A | 1 |
Rushlow, WJ; Sutton, LP | 1 |
Babin, SL; Larrison, AL; Patel, SS; Sereno, AB; Wassef, AA; Xing, Y | 1 |
Blow, FC; Chiang, C; Cunningham, F; Kales, HC; Kim, HM; Schneider, LS; Seyfried, LS; Valenstein, M; Zivin, K | 1 |
Hsu, MC; Kuo, CC; Ouyang, WC; Yeh, IN | 1 |
Alfarano, E; Carabellese, F; Catanesi, R; La Tegola, D | 1 |
Carroll, BT; Crosby, D; Peterson, J | 1 |
Uys, H | 1 |
Blazina, AR; Lara, DR; Vianna, MR | 1 |
Brown, R; Geddes, J; Taylor, MJ | 1 |
Csernansky, JG; Dong, H; Fang, D; Gallardo, C; Gerst, N; Keegan, J; Matsumoto, M; Montalvo-Ortiz, JL; Tetsuka, K; Tucker, C | 1 |
Asadollahi, S; Azadbakht, A; Hatamabadi, H; Heidari, K; Mirmohseni, L; Vafaee, R; Yunesian, S | 1 |
Boersma, NA; Heidema, J; Kuijpers, T; Schippers, H | 1 |
Barchukov, VG; Kundashev, UK; Morozov, IS; Salenko, YA; Zurdinov, AZ | 1 |
Csernansky, JG; Dong, H; Fang, D; Fisher, DW; Montalvo-Ortiz, JL; Rodríguez, G | 1 |
Ago, Y; Hara, Y; Hasebe, S; Hashimoto, H; Kawase, H; Matsuda, T; Nakazawa, T; Takuma, K; Tanabe, W; Taruta, A; Tsukada, S | 1 |
Amata, E; Dichiara, M; Floresta, G; Marrazzo, A; Parenti, C; Pittalà, V; Prezzavento, O; Rescifina, A | 1 |
Belahsen, MF; Bouchal, S; Ouali, O | 1 |
Chen, RYY; Reznik, R; Stanford, P | 1 |
Direk, M; Epcacan, S; Epcacan, Z; Okuyaz, C; Yildirim, DD | 1 |
Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Nomura, I; Okuya, M; Sakuma, K | 1 |
Cao, D; Hong, Y; Huang, W; Wang, L; Wei, H; Xu, J; Zhang, J | 1 |
Doello, K; Mesas, C; Ortiz, R; Perazzoli, G; Quiñonero, F; Rama, AR; Vélez, C | 1 |
Ahmed, SH; Irfan, M; Nashwan, AJ; Niaz, F; Shaikh, TG; Tariq, S; Ullah, I; Waseem, S | 1 |
15 review(s) available for haloperidol and valproic acid
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Problems of neurological drug therapy in pregnancy].
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Antiparkinson Agents; Carbamazepine; Chelating Agents; Female; Fetus; Haloperidol; Humans; Nervous System Diseases; Phenobarbital; Phenytoin; Pregnancy; Pregnancy Complications; Trimethadione; Valproic Acid | 1989 |
Neuropsychiatric aspects of Sydenham's chorea: a comprehensive review.
Topics: Adult; Autoimmune Diseases; Chorea; Comorbidity; Haloperidol; Humans; Mental Disorders; Obsessive-Compulsive Disorder; Rheumatic Fever; Schizophrenia; Tic Disorders; Tourette Syndrome; Valproic Acid | 1996 |
Neuroleptic malignant syndrome and severe thrombocytopenia: case report and literature review.
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Haloperidol; Humans; Male; Neuroleptic Malignant Syndrome; Schizophrenia; Thrombocytopenia; Valproic Acid | 2000 |
Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants.
Topics: Abnormalities, Drug-Induced; Acetates; Adult; Amines; Antimanic Agents; Benzodiazepines; Breast Feeding; Carbamazepine; Cyclohexanecarboxylic Acids; Female; Fetus; Gabapentin; gamma-Aminobutyric Acid; Haloperidol; Humans; Infant, Newborn; Lithium; Mood Disorders; Olanzapine; Pirenzepine; Placenta; Pregnancy; Risk Factors; Valproic Acid | 2001 |
[Organic solvent-related mental disorders].
Topics: Administration, Inhalation; Anticonvulsants; Antipsychotic Agents; Carbamazepine; Haloperidol; Humans; International Classification of Diseases; Mental Recall; Psychotherapy; Self-Help Groups; Sensation; Social Support; Solvents; Substance-Related Disorders; Valproic Acid | 2003 |
[Psychotropics and weight gain].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Body Mass Index; Child; Clozapine; Dibenzothiazepines; Double-Blind Method; Female; Fructose; Haloperidol; Humans; Imidazoles; Indoles; Male; Obesity; Olanzapine; Piperazines; Placebos; Psychotropic Drugs; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Socioeconomic Factors; Sulpiride; Thiazoles; Time Factors; Topiramate; Valproic Acid; Weight Gain | 2004 |
Haloperidol alone or in combination for acute mania.
Topics: Amisulpride; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Dibenzothiazepines; Drug Therapy, Combination; Haloperidol; Humans; Olanzapine; Piperazines; Quetiapine Fumarate; Quinolones; Randomized Controlled Trials as Topic; Risperidone; Sulpiride; Valproic Acid | 2006 |
Quetiapine for acute mania in bipolar disorder.
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Dibenzothiazepines; Drug Interactions; Drug Therapy, Combination; Haloperidol; Humans; Lithium Compounds; Quetiapine Fumarate; Valproic Acid | 2007 |
Going up in smoke: tobacco smoking is associated with worse treatment outcomes in mania.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Comorbidity; Double-Blind Method; Female; Haloperidol; Humans; Least-Squares Analysis; Male; Meta-Analysis as Topic; Olanzapine; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Severity of Illness Index; Smoking; Survival Analysis; Treatment Outcome; Valproic Acid | 2008 |
Aripiprazole alone or in combination for acute mania.
Topics: Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Haloperidol; Humans; Lithium Compounds; Piperazines; Quinolones; Randomized Controlled Trials as Topic; Valproic Acid | 2013 |
Synthesis and evaluation of haloperidol metabolite II prodrugs as anticancer agents.
Topics: Antineoplastic Agents; Cell Survival; Haloperidol; Histone Deacetylase Inhibitors; Humans; Phenylbutyrates; Prodrugs; Receptors, sigma; Signal Transduction; Valproic Acid | 2017 |
Pharmacological treatment for bipolar mania: a systematic review and network meta-analysis of double-blind randomized controlled trials.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Bipolar Disorder; Carbamazepine; Female; Haloperidol; Humans; Lithium; Male; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risperidone; Tamoxifen; Valproic Acid | 2022 |
A cumulative Bayesian network meta-analysis on the comparative efficacy of pharmacotherapies for mania over the last 40 years.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Benzodiazepines; Carbamazepine; Dibenzocycloheptenes; Haloperidol; Humans; Lithium; Mania; Network Meta-Analysis; Olanzapine; Paliperidone Palmitate; Pharmaceutical Preparations; Piperazines; Quetiapine Fumarate; Risperidone; Tamoxifen; Thiazoles; Valproic Acid | 2022 |
Managing and treating Sydenham chorea: A systematic review.
Topics: Anticonvulsants; Chorea; Dopamine Antagonists; Female; Haloperidol; Humans; Male; Valproic Acid | 2023 |
11 trial(s) available for haloperidol and valproic acid
Article | Year |
---|---|
A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania.
Topics: Acute Disease; Administration, Oral; Adult; Basal Ganglia Diseases; Bipolar Disorder; Haloperidol; Hospitalization; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Single-Blind Method; Treatment Outcome; Valproic Acid | 1996 |
Combined treatment of schizophrenic psychoses with haloperidol and valproate.
Topics: Adult; Antipsychotic Agents; Basal Ganglia Diseases; Biperiden; Brief Psychiatric Rating Scale; Chlorprothixene; Double-Blind Method; Drug Therapy, Combination; Electroencephalography; Haloperidol; Humans; Leukopenia; Schizophrenia; Valproic Acid | 1998 |
Effects of carbamazepine and valproate on haloperidol plasma levels and on psychopathologic outcome in schizophrenic patients.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Metabolic Clearance Rate; Middle Aged; Psychiatric Status Rating Scales; Psychotic Disorders; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 1999 |
Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomized, double-blind, placebo-controlled, multicenter study. European Valproate Mania Study Group.
Topics: Acute Disease; Administration, Oral; Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Middle Aged; Perazine; Prospective Studies; Psychiatric Status Rating Scales; Treatment Outcome; Valproic Acid | 2000 |
Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia.
Topics: Acute Disease; Adult; Antipsychotic Agents; Chronic Disease; Double-Blind Method; Drug Therapy, Combination; Female; GABA Agonists; Haloperidol; Humans; Male; Pilot Projects; Prospective Studies; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Valproic Acid | 2000 |
Divalproex sodium augmentation of haloperidol in hospitalized patients with schizophrenia: clinical and economic implications.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Drug Therapy, Combination; Female; Haloperidol; Hospitalization; Humans; Male; Schizophrenia; Treatment Outcome; Valproic Acid | 2001 |
Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety.
Topics: Acute Disease; Adolescent; Adult; Aged; Antimanic Agents; Antiparkinson Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Brief Psychiatric Rating Scale; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium; Male; Middle Aged; Placebos; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid | 2002 |
A prospective 4-5 year follow-up of juvenile onset bipolar disorder.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Diagnostic and Statistical Manual of Mental Disorders; Drug Administration Schedule; Female; Follow-Up Studies; Haloperidol; Humans; Imipramine; Lithium Carbonate; Male; Phenotype; Prospective Studies; Recovery of Function; Risperidone; Secondary Prevention; Severity of Illness Index; Valproic Acid | 2004 |
Efficacy of sodium valproate and haloperidol in the management of acute mania: a randomized open-label comparative study.
Topics: Adolescent; Adult; Antimanic Agents; Bipolar Disorder; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Injections, Intramuscular; Injections, Intravenous; Lorazepam; Male; Middle Aged; Severity of Illness Index; Valproic Acid | 2010 |
Efficacy and safety of combination of risperidone and haloperidol with divalproate in patients with acute mania.
Topics: Acute Disease; Adolescent; Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Body Weight; Child; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Hospitals, Psychiatric; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Treatment Outcome; Valproic Acid; Young Adult | 2012 |
Efficacy and safety of valproic acid versus haloperidol in patients with acute agitation: results of a randomized, double-blind, parallel-group trial.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Female; Haloperidol; Humans; Male; Middle Aged; Psychomotor Agitation; Valproic Acid | 2015 |
91 other study(ies) available for haloperidol and valproic acid
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Air to lung partition coefficients for volatile organic compounds and blood to lung partition coefficients for volatile organic compounds and drugs.
Topics: Air; Animals; Humans; Lung; Organic Chemicals; Probability; Rats; Tissue Distribution; Volatilization | 2008 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In silico assay for assessing phospholipidosis potential of small druglike molecules: training, validation, and refinement using several data sets.
Topics: Animals; Cattle; Cells, Cultured; Computer Simulation; Cornea; Drug-Related Side Effects and Adverse Reactions; Fibroblasts; Lipidoses; Lysosomal Storage Diseases; Models, Molecular; Pharmaceutical Preparations; Phospholipids; Structure-Activity Relationship; Thermodynamics | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Development of a cell viability assay to assess drug metabolite structure-toxicity relationships.
Topics: Adenosine Triphosphate; Benzbromarone; Cell Line; Cell Survival; Chromans; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Humans; Pharmaceutical Preparations; Thiazolidinediones; Troglitazone | 2016 |
Antiangiogenic Effect of (±)-Haloperidol Metabolite II Valproate Ester [(±)-MRJF22] in Human Microvascular Retinal Endothelial Cells.
Topics: Angiogenesis Inhibitors; Cell Survival; Dose-Response Relationship, Drug; Endothelial Cells; Haloperidol; Humans; Microvessels; Molecular Structure; Neovascularization, Physiologic; Retina; Structure-Activity Relationship; Valproic Acid | 2016 |
Structure-anticonvulsant activity studies in the group of (E)-N-cinnamoyl aminoalkanols derivatives monosubstituted in phenyl ring with 4-Cl, 4-CH
Topics: Amino Alcohols; Animals; Anticonvulsants; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Electroshock; Mice; Models, Molecular; Molecular Structure; Rats; Seizures; Structure-Activity Relationship | 2017 |
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.
Topics: Animals; Antiviral Agents; Betacoronavirus; Chlorocebus aethiops; Cloning, Molecular; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Drug Evaluation, Preclinical; Drug Repositioning; HEK293 Cells; Host-Pathogen Interactions; Humans; Immunity, Innate; Mass Spectrometry; Molecular Targeted Therapy; Pandemics; Pneumonia, Viral; Protein Binding; Protein Biosynthesis; Protein Domains; Protein Interaction Mapping; Protein Interaction Maps; Receptors, sigma; SARS-CoV-2; SKP Cullin F-Box Protein Ligases; Vero Cells; Viral Proteins | 2020 |
Haloperidol Metabolite II Valproate Ester (
Topics: Angiogenesis Inhibitors; Butyrophenones; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Melanoma; Pentanoic Acids; Piperidines; Prodrugs; Stereoisomerism; Uveal Neoplasms; Valerates | 2021 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Biochemical aspects of Huntington's chorea.
Topics: Adult; Age Factors; Blood Platelets; Brain Damage, Chronic; Dopamine; Dopamine beta-Hydroxylase; Female; Haloperidol; Homovanillic Acid; Humans; Huntington Disease; Hydroxyindoleacetic Acid; Hyperkinesis; Intelligence; Male; Middle Aged; Motor Skills; Time Factors; Valproic Acid | 1977 |
Pharmacology of Huntington's chorea. Personal experience.
Topics: Acetates; Adult; Aminobutyrates; Blood Cell Count; Bromocriptine; Female; gamma-Aminobutyric Acid; Haloperidol; Humans; Huntington Disease; Kidney Function Tests; Liver Function Tests; Male; Middle Aged; Physostigmine; Receptors, Dopamine; Valerates; Valproic Acid | 1977 |
The treatment of the choreas and athetotic dystonias.
Topics: Adult; Athetosis; Benzodiazepines; Child; Chorea; Dystonia; Haloperidol; Humans; Levodopa; Movement Disorders; Phenelzine; Phenothiazines; Pimozide; Tetrabenazine; Valproic Acid | 1979 |
Alopecia and mood stabilizers: two case reports.
Topics: Adult; Alopecia; Carbamazepine; Clorazepate Dipotassium; Depressive Disorder; Female; Fluvoxamine; Haloperidol; Hospitalization; Humans; Lithium Carbonate; Methotrimeprazine; Middle Aged; Schizophrenia; Valproic Acid | 1992 |
Importance of treatment follow-up.
Topics: Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Haloperidol; Humans; Neurocognitive Disorders; Valproic Acid | 1990 |
Clinical assessment and pharmacotherapy of the alcohol withdrawal syndrome.
Topics: Adrenergic beta-Antagonists; Alcohol Drinking; Alcoholism; Anti-Anxiety Agents; Benzodiazepines; Chlormethiazole; Combined Modality Therapy; Diagnosis, Differential; Drug Administration Schedule; Ethanol; Haloperidol; Humans; Neuropsychological Tests; Substance Withdrawal Syndrome; Valproic Acid | 1986 |
Forced normalization. Acute psychosis after seizure control in seven patients.
Topics: Adult; Anticonvulsants; Carbamazepine; Epilepsy; Female; Haloperidol; Humans; Male; Psychotic Disorders; Succinimides; Valproic Acid | 1987 |
Efficacy of valproic acid in the treatment of Sydenham's chorea.
Topics: Adolescent; Chorea; Haloperidol; Humans; Male; Valproic Acid | 1988 |
Lithium-induced downbeat nystagmus.
Topics: Adult; Bipolar Disorder; Electrooculography; Female; Haloperidol; Humans; Lithium; Middle Aged; Nystagmus, Pathologic; Valproic Acid | 1988 |
Bromocriptine-related psychosis and treatment.
Topics: Adult; Bromocriptine; Female; Haloperidol; Humans; Pituitary Neoplasms; Prolactin; Psychoses, Substance-Induced; Substance Withdrawal Syndrome; Valproic Acid | 1985 |
The effects of neuroleptics (haloperidol and chlorpromazine) on the pharmacokinetics of valproic acid in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Chlorpromazine; Drug Interactions; Electroencephalography; Female; Half-Life; Haloperidol; Humans; Kinetics; Male; Middle Aged; Schizophrenia; Valproic Acid | 1984 |
Therapeutic aspects of kinesiogenic paroxysmal choreoathetosis and familial paroxysmal choreoathetosis of the Mount and Reback type.
Topics: Adolescent; Adult; Aged; Alcohol Drinking; Athetosis; Carbamazepine; Child; Chorea; Female; Haloperidol; Humans; Male; Middle Aged; Motor Activity; Pedigree; Phenytoin; Primidone; Valproic Acid | 1983 |
[Treatment of several psychotic states with the combination of valproic acid with diazepam].
Topics: Acute Disease; Adult; Delusions; Diazepam; Drug Therapy, Combination; Female; Hallucinations; Haloperidol; Humans; Male; Middle Aged; Schizophrenia, Paranoid; Valproic Acid | 1984 |
Effect of sodium valproate and baclofen in tardive dyskinesia: clinical and neuroendocrine studies.
Topics: Adult; Baclofen; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Male; Middle Aged; Prolactin; Schizophrenia; Valproic Acid | 1980 |
Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
Topics: Aminooxyacetic Acid; Animals; Apomorphine; Dopamine; gamma-Aminobutyric Acid; Haloperidol; Humans; Levodopa; Male; Picrotoxin; Rats; Stereotyped Behavior; Valproic Acid | 1982 |
Effects of haloperidol, lithium, and valproate on phosphoinositide turnover in rat brain.
Topics: Animals; Brain Chemistry; Carbachol; Corpus Striatum; Drug Interactions; Haloperidol; Lithium; Male; Norepinephrine; Phosphatidylinositols; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Valproic Acid | 1993 |
Acute manic episodes in pregnancy.
Topics: Adult; Bipolar Disorder; Chlorpromazine; Comorbidity; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Electroconvulsive Therapy; Female; Haloperidol; Humans; Lorazepam; Pregnancy; Pregnancy Complications; Valproic Acid | 1996 |
Hyperkinesias in a prepubertal boy with autistic disorder treated with haloperidol and valproic acid.
Topics: Anti-Dyskinesia Agents; Anticonvulsants; Attention Deficit Disorder with Hyperactivity; Autistic Disorder; Bangladesh; Child; Drug Therapy, Combination; Epilepsy, Generalized; Haloperidol; Humans; Intellectual Disability; Male; Valproic Acid | 1997 |
Delirium and persistent dyskinesia induced by a lithium-neuroleptic interaction.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Delirium; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Lithium Carbonate; Middle Aged; Valproic Acid | 1998 |
The use of haloperidol and valproate in children with Sydenham chorea.
Topics: Adolescent; Alanine Transaminase; Anti-Dyskinesia Agents; Anticonvulsants; Aspartate Aminotransferases; Child; Child, Preschool; Chorea; Female; Follow-Up Studies; Haloperidol; Humans; Liver; Male; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Valproic Acid | 1998 |
Mania onset while using dehydroepiandrosterone.
Topics: Acute Disease; Bipolar Disorder; Dehydroepiandrosterone; Drug Therapy, Combination; Haloperidol; Humans; Male; Middle Aged; Valproic Acid | 1999 |
[Manic syndrome: diagnostic trends and principles of treatment].
Topics: Adult; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Carbamazepine; Chlorpromazine; Diagnosis, Differential; Haloperidol; Hospitalization; Humans; Iatrogenic Disease; Lithium; Neurocognitive Disorders; Schizophrenia; Syndrome; Time Factors; Valproic Acid | 1998 |
Cerebellar ataxia with intravenous valproate and haloperidol.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Cerebellar Ataxia; Haloperidol; Humans; Injections, Intravenous; Male; Valproic Acid | 2002 |
Effect of Withania somnifera glycowithanolides on a rat model of tardive dyskinesia.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Antioxidants; Disease Models, Animal; Dyskinesia, Drug-Induced; Ergosterol; Glycosides; Haloperidol; Male; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Sitosterols; Solanaceae; Valproic Acid; Vitamin E; Withanolides | 2002 |
Management of rheumatic chorea: an observational study.
Topics: Anti-Dyskinesia Agents; Child; Chorea; Cross-Sectional Studies; Diazepam; Female; Haloperidol; Humans; Male; Sulpiride; Valproic Acid | 2002 |
Comparison of the efficacy of carbamazepine, haloperidol and valproic acid in the treatment of children with Sydenham's chorea: clinical follow-up of 18 patients.
Topics: Adolescent; Anti-Dyskinesia Agents; Antimanic Agents; Carbamazepine; Child; Chorea; Female; Follow-Up Studies; Haloperidol; Humans; Male; Prospective Studies; Treatment Outcome; Valproic Acid | 2002 |
[Landau-Kleffner and autistic regression: the importance of differential diagnosis].
Topics: Anticonvulsants; Autistic Disorder; Child, Preschool; Diagnosis, Differential; Electroencephalography; Haloperidol; Humans; Landau-Kleffner Syndrome; Male; Promethazine; Valproic Acid | 2002 |
Effect of Emblica officinalis tannoids on a rat model of tardive dyskinesia.
Topics: Animals; Anti-Dyskinesia Agents; Anticonvulsants; Antioxidants; Brain; Disease Models, Animal; Dyskinesia, Drug-Induced; Euphorbiaceae; GABA Modulators; Haloperidol; Male; Phytotherapy; Plant Extracts; Plant Roots; Rats; Rats, Wistar; Tannins; Valproic Acid; Vitamin E | 2000 |
Lack of effect of mood stabilizers or neuroleptics on GSK-3 protein levels and GSK-3 activity.
Topics: Affect; Animals; Antimanic Agents; Antipsychotic Agents; Blotting, Western; Chlorpromazine; Clozapine; Frontal Lobe; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Haloperidol; Lithium; Rats; Rats, Sprague-Dawley; Valproic Acid | 2003 |
[Fast control of manic or mixed episodes. Atypical neuroleptics for bipolar patients].
Topics: Acute Disease; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Clinical Trials as Topic; Dopamine Antagonists; Drug Therapy, Combination; Haloperidol; Humans; Isotopes; Lithium; Olanzapine; Pirenzepine; Selective Serotonin Reuptake Inhibitors; Time Factors; Valproic Acid | 2003 |
Clinical case presentation: therapeutic challenges in adolescent-onset bipolar disorder.
Topics: Adolescent; Aggression; Anti-Anxiety Agents; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Clonazepam; Diagnosis, Differential; Education; Family; GABA Modulators; Haloperidol; Hospitalization; Humans; Irritable Mood; Lithium; Lorazepam; Male; Piperazines; Psychiatric Status Rating Scales; Sexual Behavior; Thiazoles; Valproic Acid | 2003 |
Olanzapine: new indication. New indication in acute mania: just another neuroleptic.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; France; Haloperidol; Humans; Valproic Acid | 2004 |
Valproic acid induces manifestations of simultaneous dopamine enhancement and reduction in schizophrenia.
Topics: Adult; Benztropine; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Female; GABA Agents; gamma-Aminobutyric Acid; Haloperidol; Humans; Muscarinic Antagonists; Schizophrenia; Time Factors; Valproic Acid | 2004 |
Olanzapine for injection: new formulation. No advantage in agitated patients.
Topics: Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cost-Benefit Analysis; France; Haloperidol; Humans; Injections, Intramuscular; Valproic Acid | 2004 |
A mood stabilizer with risperidone or haloperidol for mania.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Ethics, Research; Haloperidol; Humans; Lithium; Patient Selection; Placebos; Randomized Controlled Trials as Topic; Research Design; Risperidone; Valproic Acid | 2004 |
A mood stabilizer with risperidone or haloperidol for mania.
Topics: Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Double-Blind Method; Drug Therapy, Combination; Haloperidol; Humans; Randomized Controlled Trials as Topic; Research Design; Risperidone; Treatment Outcome; Valproic Acid | 2004 |
Acute pancreatitis and diabetic ketoacidosis in non-diabetic person while on treatment with sodium valproate, chlorpromazine and haloperidol.
Topics: Acute Disease; Adult; Antimanic Agents; Bipolar Disorder; Chlorpromazine; Diabetic Ketoacidosis; Diagnosis, Differential; Haloperidol; Humans; Male; Pancreatitis; Valproic Acid | 2004 |
Improvement in tardive dyskinesia with aripiprazole use.
Topics: Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Drug Interactions; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperidol; Humans; Long-Term Care; Middle Aged; Piperazines; Quinolones; Risperidone; Valproic Acid | 2005 |
Effects of chronic administration of olanzapine, amitriptyline, haloperidol or sodium valproate in naive and anhedonic rats.
Topics: Amitriptyline; Animals; Antidepressive Agents; Benzodiazepines; Eating; Haloperidol; Male; Olanzapine; Rats; Rats, Wistar; Self Administration; Sucrose; Valproic Acid | 2006 |
Use of intravenous valproate in a patient with neuroleptic malignant syndrome.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Bipolar Disorder; Creatine Kinase; Diagnosis, Differential; Female; Haloperidol; Humans; Infusions, Intravenous; Injections, Intramuscular; Neuroleptic Malignant Syndrome; Valproic Acid | 2006 |
Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour.
Topics: Animals; Antimanic Agents; Antiprotozoal Agents; Antipsychotic Agents; Behavior, Animal; Cats; Dapsone; Haloperidol; Humans; Mood Disorders; Pyrimethamine; Rabbits; Rats; Toxoplasma; Toxoplasmosis, Animal; Valproic Acid | 2006 |
Modification of spatial recognition memory and object discrimination after chronic administration of haloperidol, amitriptyline, sodium valproate or olanzapine in normal and anhedonic rats.
Topics: Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Chronic Disease; Conditioning, Operant; Discrimination, Psychological; Dose-Response Relationship, Drug; Food Preferences; Haloperidol; Male; Maze Learning; Memory; Olanzapine; Rats; Rats, Wistar; Recognition, Psychology; Space Perception; Stress, Psychological; Taste; Valproic Acid | 2007 |
Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
Topics: Adult; Akathisia, Drug-Induced; Anticonvulsants; Antimanic Agents; Antipsychotic Agents; Basal Ganglia Diseases; Bipolar Disorder; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Haloperidol; Humans; Lithium Compounds; Male; Middle Aged; Multicenter Studies as Topic; Neurologic Examination; Quetiapine Fumarate; Randomized Controlled Trials as Topic; Risk; Treatment Outcome; Valproic Acid | 2006 |
Drug-induced Brugada syndrome with ST-T wave alternans and long QT.
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Arrhythmias, Cardiac; Bipolar Disorder; Brugada Syndrome; Electrocardiography; Fatal Outcome; Haloperidol; Humans; Lithium Compounds; Long QT Syndrome; Male; Valproic Acid | 2007 |
Weight change in the acute treatment of bipolar I disorder: a naturalistic observational study of psychiatric inpatients.
Topics: Adult; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Body Mass Index; Body Weight; Drug Administration Schedule; Drug Therapy, Combination; Female; Haloperidol; Hospitalization; Humans; Lithium Carbonate; Male; Obesity; Olanzapine; Risperidone; Smoking; Valproic Acid | 2008 |
Risk of death associated with antipsychotic drug dispensing in residential aged care facilities.
Topics: Aged; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Carbamazepine; Cause of Death; Chlorpromazine; Comorbidity; Cross-Sectional Studies; Death, Sudden; Female; Haloperidol; Homes for the Aged; Humans; Male; Nursing Homes; Olanzapine; Risk; Valproic Acid; Veterans | 2007 |
Resolution of haloperidol-induced hyperprolactinemia with aripiprazole.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Aripiprazole; Bipolar Disorder; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Gynecomastia; Haloperidol; Humans; Hyperprolactinemia; Male; Piperazines; Prolactin; Quinolones; Valproic Acid | 2007 |
Antipsychotic medication dispensing and risk of death in veterans and war widows 65 years and older.
Topics: Age Factors; Aged; Aged, 80 and over; Anticonvulsants; Antipsychotic Agents; Australia; Benzodiazepines; Carbamazepine; Cause of Death; Chlorpromazine; Cohort Studies; Dementia; Female; Haloperidol; Humans; Male; Mortality; Olanzapine; Proportional Hazards Models; Retrospective Studies; Risk; Risk Factors; Survival Rate; Valproic Acid; Veterans; Widowhood | 2007 |
Specificity of the Toxoplasma gondii-altered behaviour to definitive versus non-definitive host predation risk.
Topics: Animals; Behavior, Animal; Cats; Dapsone; Haloperidol; Pyrimethamine; Rats; Species Specificity; Toxoplasma; Toxoplasmosis, Animal; Valproic Acid | 2008 |
Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation.
Topics: Acetylation; Animals; Benzodiazepines; Brain; Cell Adhesion Molecules, Neuronal; Clozapine; DNA Methylation; Extracellular Matrix Proteins; Glutamate Decarboxylase; Haloperidol; Histones; Lysine; Male; Mice; Nerve Tissue Proteins; Olanzapine; Promoter Regions, Genetic; Reelin Protein; Serine Endopeptidases; Sulpiride; Valproic Acid | 2008 |
The differential diagnoses of parkinsonism: findings from a cohort of 1528 patients and a 10 years comparison in tertiary movement disorders clinics.
Topics: Aged; Antipsychotic Agents; Cinnarizine; Cohort Studies; Diagnosis, Differential; Female; Flunarizine; Haloperidol; Humans; Male; Methotrimeprazine; Movement Disorders; Outpatient Clinics, Hospital; Parkinsonian Disorders; Psychotic Disorders; Risperidone; Severity of Illness Index; Time Factors; Valproic Acid | 2010 |
Antidepressants elevate GDNF expression and release from C₆ glioma cells in a β-arrestin1-dependent, CREB interactive pathway.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; Arrestins; beta-Arrestins; Brain Neoplasms; Cell Line, Tumor; Citalopram; Cyclic AMP Response Element-Binding Protein; Desipramine; Dose-Response Relationship, Drug; Glial Cell Line-Derived Neurotrophic Factor; Glioblastoma; Haloperidol; Imipramine; Neurotransmitter Uptake Inhibitors; Phosphorylation; Rats; RNA Interference; Selective Serotonin Reuptake Inhibitors; Signal Transduction; Transcription, Genetic; Transfection; Up-Regulation; Valproic Acid | 2011 |
Folie à deux: double case-report of shared delusions with a fatal outcome.
Topics: Adult; Anticonvulsants; Antipsychotic Agents; Benzodiazepines; Clozapine; Combined Modality Therapy; Epilepsy; Fatal Outcome; Female; Haloperidol; Humans; Nordazepam; Olanzapine; Patient Compliance; Psychotherapy; Psychotic Disorders; Schizophrenia, Paranoid; Shared Paranoid Disorder; Sibling Relations; Suicide; Valproic Acid | 2011 |
The effects of neuropsychiatric drugs on glycogen synthase kinase-3 signaling.
Topics: Animals; Antidepressive Agents; Antimanic Agents; Antipsychotic Agents; beta Catenin; Blotting, Western; Brain; Clozapine; Fluoxetine; Glycogen Synthase Kinase 3; Haloperidol; Imipramine; Immunoprecipitation; Lithium; Male; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Valproic Acid | 2011 |
Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Case-Control Studies; Cognition; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Haloperidol; Humans; Male; Saccades; Schizophrenia; Valproic Acid; Young Adult | 2011 |
Risk of mortality among individual antipsychotics in patients with dementia.
Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Benzodiazepines; Dementia; Dibenzothiazepines; Female; Haloperidol; Humans; Male; Olanzapine; Propensity Score; Quetiapine Fumarate; Retrospective Studies; Risk; Risperidone; Time Factors; Valproic Acid | 2012 |
Coexistence and independence between a mental disorder and female stalking.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Commitment of Mentally Ill; Dibenzothiazepines; Female; Forensic Psychiatry; Haloperidol; Humans; Quetiapine Fumarate; Stalking; Valproic Acid | 2013 |
Atypical neuroleptic malignant syndrome in H1N1 pneumonia.
Topics: Antimanic Agents; Antipsychotic Agents; Benzodiazepines; Creatine Kinase; Haloperidol; Humans; Influenza A Virus, H1N1 Subtype; Male; Middle Aged; Neuroleptic Malignant Syndrome; Olanzapine; Pneumonia, Viral; Schizophrenia; Treatment Outcome; Valproic Acid; Withholding Treatment | 2013 |
Prevalence and clinical presentation of HIV positive female psychiatric inpatients.
Topics: Adult; Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Comorbidity; Cross-Sectional Studies; Diagnosis, Dual (Psychiatry); Female; Haloperidol; HIV Seropositivity; Humans; Mental Disorders; Middle Aged; Mood Disorders; Patient Admission; Prospective Studies; Psychotic Disorders; Recurrence; South Africa; Substance-Related Disorders; Valproic Acid | 2013 |
The spinning task: a new protocol to easily assess motor coordination and resistance in zebrafish.
Topics: Animal Experimentation; Animals; Body Size; Clonazepam; Ethanol; Female; Haloperidol; Locomotion; Male; Psychomotor Performance; Sex Factors; Swimming; Valproic Acid; Zebrafish | 2013 |
HDAC inhibitors restore the capacity of aged mice to respond to haloperidol through modulation of histone acetylation.
Topics: Acetylation; Aging; Animals; Avoidance Learning; Benzamides; Conditioning, Psychological; Dopamine Antagonists; Genes, fos; Haloperidol; Histone Deacetylase Inhibitors; Histones; Male; Mice; Mice, Inbred C57BL; Nucleus Accumbens; Prefrontal Cortex; Pyridines; Valproic Acid | 2014 |
Successful treatment of Sydenham's chorea with intravenous immunoglobulin.
Topics: Anti-Bacterial Agents; Child; Chorea; Disease Progression; Female; Haloperidol; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Severity of Illness Index; Treatment Outcome; Valproic Acid | 2016 |
[EFFECT OF MEDIATOR-TYPE DRUGS ON HUMAN PSYCHOPHYSIOLOGICAL STATUS DURING MODEL OPERATOR ACTIVITY].
Topics: Adult; Anabasine; Attention; Belladonna Alkaloids; Benzodiazepines; Central Nervous System Stimulants; Dioxanes; Double-Blind Method; Haloperidol; Humans; Isoproterenol; Male; Propranolol; Psychophysiology; Sydnones; Task Performance and Analysis; Tranquilizing Agents; Valproic Acid; Yohimbine | 2016 |
Histone deacetylase inhibitors reverse age-related increases in side effects of haloperidol in mice.
Topics: Acetylation; Aging; Animals; Benzamides; Corpus Striatum; Dopamine Antagonists; Haloperidol; Histone Deacetylase Inhibitors; Histones; Male; Mice; Mice, Inbred C57BL; Motor Activity; Pyridines; Valproic Acid | 2017 |
Risperidone and aripiprazole alleviate prenatal valproic acid-induced abnormalities in behaviors and dendritic spine density in mice.
Topics: Animals; Aripiprazole; Autism Spectrum Disorder; Dendritic Spines; Disease Models, Animal; Dopamine; Dopamine Antagonists; Dopaminergic Neurons; Female; Haloperidol; Male; Mice; Mice, Inbred ICR; Prefrontal Cortex; Pregnancy; Prenatal Exposure Delayed Effects; Risperidone; Social Behavior; Valproic Acid | 2017 |
[Exceptionally good response to sodium valproate in patients with recurrent Sydenham's chorea].
Topics: Adolescent; Anticonvulsants; Chorea; Female; Follow-Up Studies; Haloperidol; Humans; Recurrence; Rheumatic Fever; Treatment Outcome; Valproic Acid | 2017 |
Clozapine toxicity in a CYP2D6 poor metaboliser: Additive effects of haloperidol and valproate on clozapine metabolism.
Topics: Adult; Antipsychotic Agents; Clozapine; Cytochrome P-450 CYP2D6; Drug Synergism; Haloperidol; Humans; Male; Schizophrenia; Valproic Acid; Young Adult | 2018 |
Efficacy of levetiracetam in the treatment of Sydenham chorea.
Topics: Adolescent; Anticonvulsants; Carbamazepine; Child; Chorea; Female; Haloperidol; Humans; Levetiracetam; Male; Retrospective Studies; Valproic Acid | 2020 |
Antitumor Effect of Traditional Drugs for Neurological Disorders: Preliminary Studies in Neural Tumor Cell Lines.
Topics: Adult; Apoptosis; Biperiden; Brain Neoplasms; Cell Line, Tumor; Dextromethorphan; Fingolimod Hydrochloride; Glioblastoma; Haloperidol; Humans; Levetiracetam; Methotrimeprazine; Valproic Acid | 2022 |